Justin Verghese

Justin Verghese is a seasoned professional in regulatory affairs with a strong focus on oncology and pharmacovigilance. Currently serving as Director, Oncology Portfolio Lead at Takeda from September 2022 to August 2025, Justin oversees the oncology business unit portfolio and provides guidance on complex review issues. Previous roles include Director and Associate Director positions in Global Regulatory Affairs at Novartis and Takeda, with significant contributions to product launches such as FRUZAQLA and SCEMBLIX. Justin's career began at Pfizer as a Safety Surveillance Associate, followed by impactful roles at Sanofi, where oversight of pharmacovigilance science and regulatory compliance marked Justin's contributions. Academically, Justin earned a PharmD from Rutgers University, graduating Summa Cum Laude.